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A review of executive functions in
obstructive sleep apnea syndrome
Introduction
According to the American Academy of Sleep
Medicine (1), obstructive sleep apnea syndrome
(OSAS) is characterized by repetitive episodes of
complete (apnea) or partial (hypopnea) obstruc-
tion of the upper airway during sleep. These
conditions usually result in oxygen desaturation
and arousals from sleep. Estimated prevalence of
clinically important sleep apnea is up to 4% in men
and 2% in women. The diagnosis of obstructive
sleep apnea is based on the following: (i) the
patient complains some of the following symp-
toms: unintentional sleep episodes during wakeful-
ness, daytime sleepiness, unrefreshing sleep,
fatigue, insomnia, gasping and choking, or the
bed partner reports breathing interruptions, and/or
loud snoring, and (ii) the polysomnographic
recording shows ﬁve or more respiratory breathing
events (apneas, hypopneas or respiratory effort
related arousals) per hour of sleep and evidence of
respiratory effort during all or a portion of each
respiratory event. The diagnostic criteria are also
fulﬁlled when (i) polysomnographic recording
shows 15 or more respiratory events per hour of
sleep and evidence of respiratory effort during all
or a portion of each respiratory event, and (ii) the
disorder is not better explained by another current
sleep disorder, medical or neurological disorder,
medications, or substance use disorder. The sever-
ity of OSAS varies among the patients. The
frequency of apneas and hypopneas during sleep
correlates poorly with the severity of daytime
symptoms. Excessive sleepiness is a major com-
plaint and is most evident in inactive situations
(e.g. watching television, reading, traveling as a
passenger). In severe sleep apnea extreme sleepi-
ness can occur during activities that require more
active attention (e.g. while eating, during conver-
sation, walking, or driving) (1).
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Objectives – To provide an update on recent research concerning
obstructive sleep apnea syndrome (OSAS) and executive
functions. Methods – A systematic review was carried out on reports
drawn from MEDLINE and PSYCHLIT (January 1990–December
2005) and identiﬁed from lists of references in these reports. The
selection criteria were met by 40 articles. Results – The sample sizes in
the reviewed studies varied widely and consisted mostly of selected
groups. Most patient samples were heterogeneous in terms of the
severity of OSAS. Executive functions were generally assessed with
standardized test methods. Half of the studies assessed executive
functions using only one or two tests. The most defected domains of
executive functions were working memory, phonological ﬂuency,
cognitive ﬂexibility, and planning. Continuous positive airway pressure
(CPAP) treatment improved performance times, cognitive ﬂexibility,
and planning. Deﬁcits in working memory and phonological ﬂuency
persisted. Conclusions – Executive functions are the most defected
cognitive domain in OSAS. Previous studies are aﬀected by the
heterogeneity of patient samples and the deﬁnitions of the domains of
executive functions. Executive functions in OSAS should be assessed
with a standardized neuropsychological test battery including
assessments of diﬀerent domains of executive functions.More research is
needed on the eﬃciency of CPAP treatment on executive dysfunctions.
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Common symptoms of OSAS include mood
disorders, reduced quality of life and cognitive
problems (2). Cognitive impairment in sleep apnea
has been studied since the 1980s and several
authors have offered reviews of these studies
(2–9). According to these reviews the most
common cognitive deﬁcits are seen in attention or
concentration, vigilance, memory and learning
abilities, motor performance, constructional abilit-
ies and executive functions. Both excessive daytime
sleepiness and nocturnal hypoxemia contribute to
cognitive deﬁcits (3–5). Excessive daytime sleepi-
ness has been mostly related to impairment in
attention, vigilance and memory function, while
hypoxemia correlates more with deﬁcits in execu-
tive functions (2, 4). Cognitive impairment usually
worsens with disease severity, but this tendency is
not linear (8, 9).
Beebe and Gozal (10) recently reviewed the
importance of executive dysfunction and the
involvement of the frontal cortex in OSAS. Lezak
et al. (11) deﬁne executive functions as a person’s
ability to respond in an adaptive manner to
situations and to engage successfully in independ-
ent, purposive and self-serving behavior, which is
the basis for many cognitive, social and emotional
skills. According to Beebe and Gozal (10) executive
functions in OSAS can manifest as deﬁcits in
behavioral inhibition, set-shifting, self-regulation
of affect and arousal, working memory, analysis/
synthesis, and contextual memory. Although cog-
nitive deﬁcits can, in most cases, be improved by
continuous positive airway pressure (CPAP) ther-
apy, some deﬁcits in executive function may remain
(2, 8, 10). Persistent deﬁcits raise the possibility of
permanent brain alterations (8–10). Beebe and
Gozal (10) have presented a model linking sleep
disruption, hypoxemia and dysfunction of the
frontal cortex. The model proposes that sleep
disruption and nocturnal hypoxemia and hyper-
carbia reduce the efﬁcacy of sleep-related restorat-
ive processes. This induces a variety of biochemical
and cellular stresses and leads to disruption of the
functional homeostasis and altered neuronal and
glial viability within certain brain areas. The model
suggests that these biochemical and cellular events
are primarily manifested in dysfunction of frontal
regions on the brain cortex. Furthermore, it is
important to notice that executive dysfunction may
also result from injury to other brain regions than
the frontal cortex (11). Frontal lobes have dense
connections to other cortical lobes and to subcor-
tical brain areas. Thus, frontal lobe dysfunction
may also result from damage to these connections.
In OSAS patients executive dysfunctions are
usually mild and they manifest in more demanding
activities, such as social relations, traﬃc, and job
tasks (10). Therefore, executive functions must
always be assessed as a part of a neuropsycholog-
ical evaluation. In OSAS patients the evaluation of
executive skills is even more critical than the
evaluation of basic cognitive skills (e.g. vocabu-
lary) or skills that only partially reﬂect executive
issues (e.g. intelligence tests) (10). Executive func-
tions are not usually impaired across the board,
but some executive functions are impaired while
others are not (12). Therefore, the neuropsycho-
logical assessment must comprise several domains
of executive functions so that any impairments and
their nature can be detected and analyzed. Among
the studies reviewed, Decary et al. (4) and Beebe
and Gozal (10) have proposed recommendations
on which executive functions and which tests
should be included in the neuropsychological
assessment of OSAS patients. An overview of
these recommendations is presented in Table 1.
The psychometric values (e.g. test–retest reliability,
inter-item consistency and interrater reliability) of
these tests as a guide to test choice are limited
because these tests often measure abilities such as
Table 1 Overview of methods recommended for the assessment of executive functions in OSAS by Decary et al. (4) and Beebe and Gozal (10)
Test method Domain of executive function
Wisconsin Card Sorting Test (13) Mental set shifting (4, 10) and abstract behavior (4)
Trails B of Trail Making Test (14) Mental set shifting (4, 10) and abstract behavior (4)
Trail Making Test (14) Conceptual and visuomotor tracking (4)
Mazes (WISC-III; 71) Planning and foresight (4)
Stroop test (15) Focal attention, shifting processes (4) and behavioral inhibition (4, 10)
Copy of Rey-Osterreith Complex Figure (64) Organizational skills/analysis-synthesis on the spatial domain (4, 10)
Fluency tasks (11) Analysis/synthesis (10)
Back digit strings (WAIS-R; 65) Working memory (10)
Visual sequences (11) Working memory (10)
N-back test (11) Working memory (10)
Behavior Rating Inventory of Executive Functioning (72) Self-regulation of affect and arousal (10)
WISC-III, Wechsler Intelligence Scale for Children – Third Edition; WAIS-R: Wechsler Adult Intelligence Scale-Revised.
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response to novelty or strategy formation, which
are one-shot tests (12). Most of the tests also allow
for retesting (Table 1), bearing in mind the impact
of learning effect. Particularly high learning effects
(4) have been reported in the Wisconsin Card
Sorting Test (WCST) (13), the Trail Making Test
(TMT) (14), and the Stroop Test (15). According
to Burgess (12) the use of a wide battery of
executive tests helps to overcome the problem that
there is no common agreement about the aspects of
executive skills that are actually measured in the
most widely used neuropsychological tests or about
the extent to which they are indicators of real-
world impairment. The use of a wide variety of
tests provides for greater coverage of many differ-
ent functions. The disadvantage of this approach is
that it increases the likelihood of false-positive
results.
Our review oﬀers a systematic update on recent
research ﬁndings over the past 15 years (from
January 1990 to December 2005) concerning exe-
cutive functions in OSAS. We wanted to focus on
how executive functions have been assessed in
OSAS, with special emphasis on the following
aspects: (i) what generalizations can be made from
previous studies based on the number of subjects,
the presence of a control group, severity of OSAS,
and other main background variables, (ii) what
tests have been used to assess executive functions,
(iii) what domains of executive functions are
diﬀerent tests thought to measure, (iv) which
executive functions are most frequently defected,
and (v) what impacts does CPAP treatment have
on executive functions?
Materials and methods
Main terms used in the search
Obstructive sleep apnea syndrome is described in
the literature by a variety of concepts: obstructive
sleep apnea (OSA), OSAS, obstructive sleep apnea-
hypopnea syndrome (OSAHS), sleep apnea-hypop-
nea syndrome (SAHS) and obstructive sleep-dis-
ordered breathing. The term that appears most
frequently is obstructive sleep apnea, which is
what we decided to use in our search. Instead of
executive functions, we used the broader terms of
cognitive or neuropsychological in order to
identify as many studies as possible that were at
least partially concerned with executive functions.
Selection of the articles
The ﬁrst step was to search the Cochrane Library
database to see whether there were any recent or
ongoing reviews on this subject, but we found
none. We searched MEDLINE and PSYCHLIT
for articles published between January 1990 and
December 2005. The search was carried out using
the terms obstructive sleep apnea and cognitive or
obstructive sleep apnea and neuropsychological. We
found a total of 196 articles. The exclusion criteria
were: (i) non-English articles, (ii) studies of non-
human, and (iii) non-adult subjects (<19 years).
There now remained 107 articles. Next, we
excluded case reports, reviews, experimental
studies, letters, commentaries, abstracts, and chap-
ters of edited volumes. This left us with 47 articles.
The full articles of these 47 studies were reviewed.
Studies that were exclusively concerned with other
aspects of cognition than executive functions were
excluded. All studies that reported the results of
even one executive function were included. This
criterion was met by 24 of the 47 articles. The lists
of references of these 24 studies were searched; this
yielded 16 additional articles. The total number of
articles reviewed for this study was thus 40.
Results
Demographic and clinical data
The number of the patients in our review ranged
from 8 to 199 (median: 24). In one case (16) it was
not possible to establish the number of patients, as
this was a population-based study and the number
of healthy controls and the number in the patient
group were not differentiated. The mean age of
patients ranged from 40 to 65 years (median:
49 years). Three studies (16–18) did not report
the mean age for the patient group. Education in
years ranged from 9 to 15 (median: 13 years).
Education was not speciﬁed in 19 studies (18–36)
and in ﬁve studies education was reported as a
categorical variable (16, 17, 37–39). The propor-
tion of men in the study samples ranged from 47%
to 100%. In 83% of the studies the patient group
consisted mainly (‡75%) of men. Two studies (20,
40) did not specify the gender of their patients.
Furthermore, two studies (16, 17) reported gender
only for the whole group, without specifying the
gender breakdown for the patient group.
The severity of sleep apnea in the patient groups
was reported in 39 studies. One study (16) reported
the severity of sleep-disordered breathing only for
the total group. If the severity of sleep apnea was
not clearly deﬁned, it was categorized on the basis
of the range of obstructive breathing events per
hour (mild: from 5 to 15 events, moderate: from 15
to 30, and severe: >30). Homogeneous patient
groups with mild sleep apnea were studied in ﬁve
Executive functions and sleep apnea
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studies (18, 26, 31, 41, 42) and with severe sleep
apnea in four studies (24, 36, 43, 44). The rest of
the studies comprise heterogeneous patient groups
in terms of the severity of OSAS. Patients with
moderate to severe sleep apnea were studied in 14
studies (19, 20, 23, 27, 28, 30, 32, 33, 35, 45–49) and
with mild to severe sleep apnea in 13 studies (17,
21, 22, 29, 37–40, 50–54). For three studies (25, 34,
55) it was not possible to establish the range of the
severity of OSAS.
Patient selection
A selected group of patients was recruited in 29 of
the 40 studies (18–20, 24, 25, 28, 30, 31, 33–38, 41–
55). In nine studies the patient sample was drawn
from consecutive cases (21–23, 26, 27, 29, 32, 39,
40). Two were population-based studies using
consecutive samples (16, 17).
Description of the control groups
A control group was included in 31 studies. The
OSAS patients performance was compared with
healthy controls in 15 studies (17, 23, 27, 30, 35, 36,
41–43, 45, 47, 49–52). In nine of these studies (17,
35, 41, 43, 45, 47, 49, 51, 52) the controls
healthiness was ensured by polysomnographical
measurement and in six studies (23, 27, 30, 36, 42,
50) with the exclusion criteria of no evidence of
sleep disorder based on an interview and/or on a
physical examination and/or on sleepiness scales.
In six studies the OSAS patients performance was
compared with other patient group(s): patients
with multi-infarct dementia, patients with mild to
moderate dementia of Alzheimer type and patients
with severe chronic obstructive pulmonary disease
(COPD) (40), COPD patients only (55), patients
with carbon monoxide poisoning (44), heavy non-
apnetic snorers (46), and insomniacs (48, 54).
In 10 CPAP treatment eﬃciency studies, OSAS
patients with eﬀective CPAP were compared with
OSAS patients receiving other treatment: placebo
treatment by tablet (18, 22, 26, 28, 31), placebo
treatment by ineffective CPAP (33, 34), or conser-
vative treatment (20, 37). In one of these 10 studies
the efﬁciency of auto-CPAP was compared with
constant-CPAP (25).
Assessment of executive functions
The neuropsychological tests used most often for
the measurement of executive functions in our
review are listed in Table 2. Table 2 also describes
which domains of executive functions the tests are
thought to measure and how many studies repor-
ted the results of these tests. Nine studies (17, 22,
26, 28, 37, 45, 47, 51, 55) used only version B of the
TMT and two studies (38, 41) used only the Digit
Span backwards. Some studies also used less
common tests that according to the authors are
sensitive to frontal lobe and executive dysfunction:
the Verbal Analogy Test (56), which measures
verbal intelligence and deductive thinking (40);
Generating an optimal telegram task (57), which
measures the efﬁciency of logical reasoning (54);
the Category test (11), which measures abstract
thinking and mental ﬂexibility (55); the Digit
Symbol Substitution Task computerized version
from the revised Wechsler Adult Intelligence Scale
(58), which measures processing speed, coordina-
tion, and working memory (35); the 2-back verbal
working memory task (11), which measures work-
ing memory (36); the Park and Holzman’s proce-
dure (59), which measures spatial working memory
(51); and the Mental control from the Wechsler
Memory Scale (60), which measures simple track-
ing (55). In addition, the following four tests were
used without specifying any particular domain of
executive function: the Temporal Rule Induction
(40, 61), the D2 test (52, 62), the Five-Point Test
(11, 49), and the Serial subtraction task (11, 41,
51).
Table 3 shows the number of tests measuring
executive functions in each study. Twenty studies
used only one or two tests to assess executive
functions. Most treatment efﬁciency studies used
the same executive tests for purposes of retesting
(18, 20, 21, 22, 25, 26, 28, 31, 32, 36, 37, 39, 44). Six
studies (27, 30, 33, 34, 43, 47) used partly or totally
alternative or parallel versions of the tests.
OSAS patients pre-treatment performance compared with
healthy controls in the executive functions
Obstructive sleep apnea syndrome patients pre-
treatment performance was compared with
healthy controls to identify the executive tests in
which the patients performance was most often
defected (Table 4). Impaired test performances
were found most frequently in the Digit Span
forwards and backwards (23, 27, 41, 49, 52), in
the Corsi’s block-tapping test (23, 27), in the
phonological ﬂuency task (43, 45, 47, 50), in the
copy of the Rey-Osterreith Complex Figure Test
(ROCFT) (43, 45, 47, 52), in the Mazes test (45,
47, 52), and in the perseverative errors of the
WCST (23, 27, 41, 51). The Double encoding task
(23, 27), the 2-back test (36) and the Raven’s
progressive matrices (43) were rarely used, but
showed signiﬁcant impairment in the studies that
applied these tests.
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Impact of the CPAP treatment on executive test performance
Nineteen of the 40 studies included an evaluation
of treatment eﬃciency (18, 20, 22, 24, 25–28, 30–
34, 36, 37, 39, 43, 44, 47). Most of these studies
(89%) used CPAP treatment (18, 20, 22, 24, 25–28,
30–34, 36, 43, 44, 47). Both CPAP and uvulopa-
latopharyngopalsty surgery (UPPP) were used in
one study (37). In one study (39) UPPP was used as
the only method of treatment.
Minimum CPAP treatment time in the 18 studies
ranged from 1 week to 12 months (median:
8 weeks). Fifteen studies (18, 20, 22, 25–28, 30–
34, 36, 44, 47, 51) conducted one follow-up, and
three studies (24, 37, 43) conducted two follow-ups.
Table 2 The most commonly used tests for assessing executive functions in OSAS patients
Test method Domain of executive function No. of studies using the test
Fluency tasks (11) of which: 24
(a) Phonological Language (40, 53) 21
Cognition (18)
Planning abilities (40)
Verbal cognitive speed and ability to retrieve words from lexical memory (17)
Verbal fluency/production ability (22, 26, 28, 43, 45, 47)
Not specified (16, 23, 27, 30, 33, 34, 38, 44, 50–52)
(b) Semantic Conceptual semantic knowledge (40) 3
Language (53)
Not specified (50)
Trail Making Test: Trails A and B (14) Cognitive set shifting and flexibility (43, 49) 20
Attentional capacity (23, 27, 30)
Visuomotor activity and visual search (49)
Processing speed (53)
General cognitive function (18, 20)
Not specified (19, 21, 25, 29, 31–34, 38, 41, 44, 52, 53)
Digit Span forwards and backwards (65) Short-term, immediate memory (23, 27, 30, 43, 55) 14
Working memory (23, 30, 42, 43, 49, 51, 53)
Memory efficiency (27, 30)
Central executive memory (49)
Attention (42, 52)
Not specified (24, 33, 34, 44)
Wisconsin Card Sorting Test (13) Abstract reasoning ability (39) 11
Contextual flexibility, shifting (39, 42)
Not specified (23, 27, 30, 38, 41, 50–53)
Stroop test (15) Attentional capacity (18, 23, 27, 30, 46, 48) 9
Inhibition (43, 46, 48)
Not specified (23, 49)
Tower tests (11) Not specified (23, 27, 30, 51, 53) 5
Copy of Rey-Osterreith Complex Figure Test (64) Perceptual organization (42) 5
Visuo-constructional abilities (43)
Not specified (45, 47, 52)
Corsi's block-tapping test (11) Short-term memory (23, 27, 30, 43) 5
Working memory (23, 30)
Memory efficiency (27)
Visual attention (42)
Raven's progressive or colored matrices (66, 67) Nonverbal reasoning (43) 4
Reasoning in visuospatial modality (40, 46, 48)
Mazes tests (11) Planning and problem solving (54) 4
Not specified (45, 47, 52)
Double encoding task (e.g. 23) Short-term memory (23, 27, 30) 3
Working memory (23, 30)
Memory efficiency (27, 30)
Twenty questions procedure (68) Strategy formation in verbal problem-solving (23, 27, 30) 3
Table 3 Number of neuropsychological tests assessing executive functions in
the studies reviewed
No. of test(s) in each study No. of studies
One test 13 (16, 19–21, 24, 25, 29, 31, 32, 36, 37, 39, 40)*
Two tests 7 (17, 22, 26, 28, 46, 48, 54)
Three tests 4 (18, 34, 44, 50)
Four tests 9 (33, 38, 40–42, 45, 47, 49, 55)
Five tests 0
Six tests 1 (53)
Seven tests 2 (51, 52)
Eight tests 1 (43)
Nine tests 3 (23, 27, 30)
*Numbers in parentheses refer to the original articles reviewed.
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In 12 studies (18, 20, 22, 25, 26, 28, 30–34, 43)
compliance to therapy ranged from 3.2 to 6.5 h per
night (median: 5.3 h). Two studies (36, 37) repor-
ted only the minimum demanded using hours per
night. Four studies (24, 27, 44, 47) did not specify
compliance.
Among the studies measuring CPAP treatment
eﬃciency ﬁve (27, 30, 36, 43, 47) included a healthy
control group at the baseline evaluation. In nine
studies the control group consisted of OSAS
patients: in seven of them (18, 22, 26, 28, 31–33)
the control group used placebo treatment and in
the other two (20, 37) conservative treatment. Two
studies (24, 32) did not have a control group. One
study (44) used a group of patients with carbon
monoxide poisoning as a control group at the
baseline evaluation. In one study (25) auto-CPAP
was compared with constant-CPAP.
The impact of CPAP treatment on executive
functions in the ﬁve studies (27, 30, 36, 43, 47)
including a healthy control group is described in
Table 5. CPAP treatment improved efﬁciently
performance time in the Stroop test (27, 30),
decreased perseverative errors in the WCST (27,
30) and improved performance in the Mazes test
(47). Improvement was also seen in one (47) of the
two studies using the copy of the ROCFT. None of
these studies included a healthy control group in
the follow-up phase.
Table 4 OSAS patients pre-treatment performance compared with the healthy control group in the tests of executive functions
Test
Naegele
et al. (23)
Lee
et al. (51)
Feuerstein
et al. (27)
Verstraeten
et al. (49)
Redline
et al. (41)
Ferini-Strambi
et al. (43)
Rouleau
et al. (52)
Salorio
et al. (50)
Laakso
et al. (42)
Bedard
et al. (45)
Bedard
et al. (47)
Thomas
et al. (36)
Digit-f + o + + na o +* na o* na na na
Digit-b + o + o + o +* na o* na na na
Corsi + na + na na o na na o na na na
DET + na + na na na na na na na na na
2-back na na na na na na na na na na na +
TMT-A o o o o o o na na na na na na
TMT-B o o o o o o o na o + + na
Stroop-t + na + o na o na na na na na na
Stroop-e na na na o na + na na na na na na
WCST-c + o o na na na + o na na na na
WCST-e + + + na + na o o na na na na
Tower + o o na na na na na na na na na
TQP o na o na na na na na na na na na
Fluency-p o na o na na + o + na + + na
Fluency-s na + na na na o na o na na na na
ROCFT na na na na na + + na o + + na
Raven na na na na na + na na na na na na
Mazes na na na na na na + na na + + na
Digit-f, the Digit Span forwards; Digit-b, the Digit Span backwards; Corsi, the Corsi's block-tapping test; DET, the Double encoding task; 2-back, the 2-back verbal working
memory task; TMT-A, the Trail Making Test, Trails A; TMT-B, the Trail Making Test, Trails B; Stroop-t, performance time in the Stroop test; Stroop-e, errors in the Stroop test;
WCST-c, categories achieved in the Wisconsin Card Sorting Test; WCST-e, perseverative errors in the Wisconsin Card Sorting Test; Tower, the Tower tests; TQP, the Twenty
questions procedure; Fluency-p, the Phonological fluency tasks; Fluency-s, the Semantic fluency tasks; ROCFT, the copy of the Rey-Osterreith Complex Figure Test; Raven, the
Raven's Progressive Matrices; Mazes, the Mazes Tests. + indicates impairment between OSAS patients and healthy control group; o indicates no difference between OSAS
patients and healthy control group; na indicates that the cognitive domain was not assessed in the study.
*In the studies by Laakso et al. (42) and Rouleau et al. (52) the Digit Span was reported as a sum of the Digit Span forwards and backwards.
Table 5 Impact of CPAP treatment on executive test performance in studies
including a healthy control group
Test
Feuerstein
et al.
(27)
Ferini-Strambi
et al.
(43)
Naegele
et al.
(30)
Bedard
et al.
(47)
Thomas
et al.
(36)
Digit-f o x o na na
Digit-b o x o na na
Corsi o x o na na
DET o na o na na
2-back na na na na o
TMT-B x x x o na
Stroop-t + x + na na
Stroop-e na o na na na
WCST-c x na o na na
WCST-e + na + na na
Fluency-p x o x o na
ROCFT na o na + na
Raven na o na na na
Mazes na na na + na
Digit-f, the Digit Span forwards; Digit-b, the Digit Span backwards; Corsi, the
Corsi's block-tapping test; DET, the Double encoding task; 2-back, the 2-back
verbal working memory task; TMT-B, the Trail Making Test, Trails B; Stroop-t,
performance time in the Stroop test; Stroop-e, errors in the Stroop test; WCST-c,
categories achieved in the Wisconsin Card Sorting Test; WCST-e, perseverative
errors in the Wisconsin Card Sorting Test; Fluency-p, the Phonological fluency
tasks; ROCFT, the copy of the Rey-Osterreith Complex Figure Test; Raven, the
Raven's progressive matrices; Mazes, the Mazes Tests. x indicates that per-
formance in the test was not impaired pre-treatment; + indicates improvement
with CPAP treatment; o indicates no change in test performance with CPAP
treatment; na indicates that the cognitive domain was not assessed in the
study.
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In the studies (18, 20, 22, 25, 26, 28, 31, 33, 34,
37) that compared the performance of OSAS
patients receiving CPAP treatment with patients
receiving placebo or conservative treatment, exe-
cutive functions were assessed with the Digit Span
forwards and backwards, the Trails A and B, the
Stroop test, and the phonological ﬂuency task.
Improvement was usually seen in executive test
performance, but only three studies reported sig-
niﬁcantly better improvement with CPAP than
with placebo or conservative treatment: this was in
two (22, 26) of nine studies using the Trails B, and
in one (18) of six studies using the phonological
ﬂuency task.
Discussion
This review provides an update on recent research
ﬁndings concerning executive functions in OSAS,
with special emphasis on the following aspects: the
generalizability of former studies based on patient
characteristics and the presence of a control group,
the methods used in assessing executive functions,
the domains of executive functions that diﬀerent
tests are thought to measure, the executive func-
tions that are most often defected, and the possible
eﬀect of CPAP treatment on executive functions.
The sample size in the studies reviewed ranged
from 8 to 199 (median: 24). Among the 40 studies
19 had less than 24 patients. This wide variability
in sample sizes very much undermines the com-
parability of the diﬀerent studies as well as the
statistical analysis of the results. The mean age of
patients ranged from 40 to 65 years, representing
the population of working age which is an
important target group for neuropsychological
assessment. Most of the studies (73%) recruited
heterogeneous patient groups consisting of selected
samples. Only half of the studies speciﬁed the
patients educational level, even though this is
usually thought to be one of the most important
background variables aﬀecting cognitive test per-
formance. In the studies reviewed the patient
samples consisted primarily of men, but it is
important to note that the estimated prevalence
of OSAS in females is up to 2% (63). Twenty-ﬁve
percent of the studies reviewed had homogeneous
patient groups in terms of the severity of OSAS,
which can signiﬁcantly affect the appearance of
executive dysfunction. In the studies that involved
heterogeneous patient groups with patients from
mild to severe OSAS, the mean number of
obstructive breathing events is not informative
enough as a single measure of OSAS severity. The
range of obstructive breathing events and the
number of patients in different severity groups
should therefore be reported in detail. To conclude,
the generalizability of the studies reviewed is
undermined by the variation in sample sizes, the
heterogeneity of patient groups, the overrepresen-
tation of male patients, inadequate reporting on
education, and inaccuracies in deﬁning the severity
of OSAS.
A control group was used in 31 of the 40 studies:
a healthy control group was used in 15 studies,
other patient groups in six studies (patients with
multi-infarct dementia or dementia of Alzheimer
type, patients with COPD, patients with carbon
monoxide poisoning, heavy non-apnetic snorers,
and insomniacs), and in 10 studies OSAS patients
receiving CPAP treatment were compared with
OSAS patients receiving placebo or conservative
treatment. As Aloia et al. (8) have pointed out, the
use of a control group is scientiﬁcally more
rigorous than the use of normative comparisons.
In our review, we analyzed the pre-treatment
executive function of OSAS patients in comparison
with a healthy control group, because we wanted to
evaluate the nature of executive dysfunction in
OSAS patients compared with the healthy popula-
tion. It is misleading to compare executive func-
tions in OSAS patients with other patient groups as
cognitive defects are common sequelae in patients
suffering from dementia, COPD or carbon mon-
oxide poisoning, for example. The healthy control
group should be matched to the patient group at
least according to age, gender and education, and
the healthiness of the control group should be
assessed by polysomnographic measurement as
even asymptomatic healthy volunteers can suffer
from mild obstructive breathing events. In our
ongoing study a signiﬁcant number of healthy
controls have had to be excluded after polysom-
nography ﬁndings, even though they reported
being asymptomatic in the screening interview.
The test methods that were used most often for
evaluating executive functions in the studies
reviewed were partly the same as those recommen-
ded by Decary et al. (4) and Beebe and Gozal (10):
the WCST (13), the TMT (14), the Stroop test (15),
the copy of the ROCFT (64), the Mazes tests
(11), the ﬂuency tasks (11), the Digit strings (Digit
Span forwards and backwards; 65), and the Visual
sequences (the Corsi’s block-tapping test; 11). In
addition, the Tower tests (11), the Raven’s matrices
(66, 67), the Twenty questions procedure (68), and
the Double encoding task (23) were also used in the
studies reviewed to assess executive functions.
Some studies furthermore used less common tests
to assess executive dysfunction. In some studies the
authors failed to specify what particular domain of
executive function they wanted to measure with a
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single test, but they set about assessing executive
function as a single global function. This may lead
to the false conclusion that executive function
per se is totally impaired or totally intact. Even in
the most commonly used executive tests there were
diﬀering uses as to what the test was thought to
measure. Some authors (18, 53) suggested that the
test (e.g. the ﬂuency tasks and the copy of the
ROCFT) was an assessment of a basic cognitive
skill, others (23, 42, 51) thought the same test
evaluated executive functions. The Digit Spans and
the Corsi’s block-tapping test were in most cases
thought to assess short-term and working memory,
but also attention. The TMT was conducted as a
method of attention, processing speed, visuomotor
function and cognitive ﬂexibility. The Stroop Test
was used to measure both attention and inhibition.
The ROCFT and the Raven’s matrices were seen as
test methods of executive function from a visual
point of view while the Twenty question procedure
was considered to evaluate executive function from
a verbal perspective. Studies using the WCST, the
Tower tests, and the Mazes tests did not normally
specify the domain of executive function. Half of
the studies used only one or two methods for
assessing executive functions. However, this does
not provide a sufﬁciently sound basis for drawing
conclusions and it is possible that neuropsycho-
logical assessment fails to detect dysfunction in
some important domains of executive functions
that may still have a negative inﬂuence on the
OSAS patient’s daily performance. This variability
in the testing of executive functions and in the
domains they are thought to measure very much
complicates the interpretation of the results and
undermines their comparability.
Some studies concluded that neuropsychological
tests are not sensitive enough to detect mild
executive or other cognitive dysfunction (37, 51)
and that this is most evident in patients with high
general intelligence (37). According to Alchanatis
et al. (69) high intelligence may have a protective
effect against OSAS-related cognitive decline; cog-
nitive reserve and a high level cognitive functioning
can compensate for both hypoxic brain dysfunc-
tion and daytime somnolence. According to Ver-
straeten et al. (49) it is always necessary to control
for attentional capacity when assessing executive
function. They report that OSAS patients suffer
from sleepiness-related vigilance and attention
deﬁcits, but not speciﬁc hypoxemic-related execu-
tive attentional problems. They make the critical
comment that many former studies have attributed
attentional problems to executive deﬁcits because
they have failed to control for attentional capacity.
This means that when executive function is
assessed by means of the Trails B, for example,
attention capacity should always be controlled
with the Trails A; and when working memory is
assessed with the Digit Span backwards, memory
span should ﬁrst be controlled with the Digit Span
forwards.
Twelve studies (23, 27, 36, 41–43, 45, 47, 49–52)
compared executive functions in OSAS patients
with healthy controls. All these studies used a
sufﬁcient combination of executive tests (from
three to nine tests), except one study (36) which
included only one executive task. The most fre-
quently defected performances were found in the
Digit Span forwards and backwards, in the Corsi’s
block-tapping test, in the phonological ﬂuency
tasks, in the copy of the ROCFT, in the Mazes
tests, and in the WCST. The domains of executive
function impaired most often were working
memory, phonological ﬂuency, cognitive ﬂexibility,
and planning (especially its non-verbal aspect).
In the ﬁve studies (27, 30, 36, 43, 47) where
OSAS patients performance was compared with
healthy controls at baseline only, CPAP treatment
improved cognitive ﬂexibility and speed, and also
planning in non-verbal tests. It should be noted
that none of these studies used a control group at
follow-up phase to control for the learning effect,
although most of them (four out of ﬁve; 27, 30, 43,
47) did use an alternative or parallel version of the
tests for this purpose. The studies in which learning
effect was controlled with OSAS patients having
placebo or conservative treatment, used only two
or three tests to assess executive functions. In these
studies cognitive performance generally improved,
but the improvement with CPAP treatment was
signiﬁcantly better than with placebo or conserva-
tive treatment in only three (18, 22, 26) out of nine
studies (18, 20, 22, 26, 28, 31, 33, 34, 37). In order
to establish the true effects of CPAP treatment it is
important to control for the learning effect of the
tests. To conclude, the deﬁcits of working memory
persisted after CPAP treatment, and only one
study reported an improvement in phonological
ﬂuency.
We are currently working in an ongoing study to
explore the quantity and quality of executive
dysfunction in OSAS patients compared with
healthy controls and to assess the impact of
CPAP treatment on executive functions. We use a
comprehensive battery of executive tests to assess
diﬀerent domains of executive function, both
paper-and-pencil tasks and computer-assisted
tests (CANTAB; 70). Evaluations of general intel-
lectual ability are also included. A healthy control
group is included both at baseline and at the
follow-up phase.
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Our review and the preliminary ﬁndings of our
ongoing study suggest several recommendations
for further research. First, more attention should
be paid to the number of subjects, to the
background variables that may aﬀect cognitive
performance, and to having an adequate control
group. The number of subjects in studies con-
cerning neuropsychological deﬁcits in OSAS
should be large enough for statistical analyses,
the severity of OSAS in the patient group should
be reported in detail, the healthiness of healthy
controls should be ensured with polysomnogra-
phy, and the learning eﬀect on executive test
performance should be controlled in treatment
eﬃciency studies either with a healthy control
group both at baseline and the follow-up, or with
a control group of OSAS patients receiving
placebo or conservative treatment. Second, for
purposes of assessing executive functions in
OSAS patients it is necessary to create a com-
prehensive test battery using the most common
executive tests (4, 10) so that different domains
of executive function can be measured. In addi-
tion to neuropsychological tests, self-assessing
inventories and a structured interview of patients
and their relatives are needed in order that any
executive dysfunctions can be detected. Third, it
is essential that cognitive and especially executive
function in OSAS patients is assessed when they
have a reduced capacity for working or driving.
Fourth, more research and discussion are needed
on the impact of CPAP treatment on executive
functions, as there are only a few treatment
efﬁciency studies that control for the learning
effect.
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